Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial
Status:
Completed
Trial end date:
2017-06-02
Target enrollment:
Participant gender:
Summary
This study aim to evaluate whether intensive lipid lowering therapy may improve the clinical
outcomes in coronary artery disease patients with in-stent neoatherosclerosis, in comparison
with standard therapy.